2009 •
Efficacy of alternate day versus daily dosing of rosuvastatin
Authors:
Daisy Dulay, Stephen A. LaHaye, Karen A. Lahey, Andrew G. Day
Abstract:
Background Compared with other statins, rosuvastatin has a relatively long half-life, which may allow for the administration of this medication on an alternate day basis. Objective To compare the efficacy of administering rosuvastatin on a daily basis versus on an alternate day basis for the treatment of dyslipidemia. Methods In the present crossover study, 45 patients with documented hypercholesterolemia requiring pharmacotherapy were administered either 20mg of rosuvastatin on alternate days or 10mg of rosuvastatin daily for six weeks. After (...)
Background Compared with other statins, rosuvastatin has a relatively long half-life, which may allow for the administration of this medication on an alternate day basis. Objective To compare the efficacy of administering rosuvastatin on a daily basis versus on an alternate day basis for the treatment of dyslipidemia. Methods In the present crossover study, 45 patients with documented hypercholesterolemia requiring pharmacotherapy were administered either 20mg of rosuvastatin on alternate days or 10mg of rosuvastatin daily for six weeks. After a four-week washout period, patients were then switched to the other regimen for another six weeks. The primary end point was the percentage reduction of low-density lipoprotein cholesterol (LDL-C). Results LDL-C decreased by 48.5% versus 40.9% with daily and alternate day dosing, respectively. This represented an additional absolute reduction of LDL-C of 7.6% (95% CI 1.8% to 13.4%, P=0.012) with the daily dosing regimen. Both dosing regimens provided similar improvements in high-density lipoprotein cholesterol and triglycerides. Conclusions Compared with alternate day dosing, daily dosing of rosuvastatin provides a statistically significant advantage in LDL-C reduction. However, the alternate day regimen may be a viable option for those patients in whom cost is a limitation to compliance. (Read More)
Daisy Dulay, Stephen A. LaHaye, Karen A. Lahey, Andrew G. Day
Canadian Journal of Cardiology ·
2009
Pharmacology |
Internal medicine |
Urology |
We have placed cookies on your device to help make this website and the services we offer better. By using this site, you agree to the use of cookies. Learn more